drugset
drugset / Trial / NCT01922856

Challenge Study of an ETEC Vaccine

NCT01922856 ↗

Phase 2 Completed 56 enrolled U.S. Army Medical Research and Development Command
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to determine the efficacy of a vaccine against enterotoxigenic E. coli (ETEC)-caused diarrhea.

Timeline

Start
2013-09-19
Primary completion
2016-02-06
Completion
2016-07-14

Drugs

EvaluationDrugModalityDoseRoute
Subject LTR192G Protein / enzyme biologic — Intravenous
Subject dscCfaE Protein / enzyme biologic — Intravenous

Indications

enteritis